OncoLens Revenue and Competitors
Estimated Revenue & Valuation
- OncoLens's estimated annual revenue is currently $10.8M per year.
- OncoLens's estimated revenue per employee is $337,500
- OncoLens's total funding is $23M.
Employee Data
- OncoLens has 32 Employees.
- OncoLens grew their employee count by -18% last year.
OncoLens's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder and CEO | Reveal Email/Phone |
2 | CEO and Co-Founder | Reveal Email/Phone |
3 | VP Business Development | Reveal Email/Phone |
4 | Co-founder and Chief Medical Officer | Reveal Email/Phone |
5 | Director Business Development | Reveal Email/Phone |
6 | Director, Oncology Strategy | Reveal Email/Phone |
7 | Director DevOps | Reveal Email/Phone |
8 | Director Product, Life Sciences | Reveal Email/Phone |
9 | Director Enablement | Reveal Email/Phone |
10 | Strategic Account Director | Reveal Email/Phone |
OncoLens Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.5M | 29 | -6% | N/A | N/A |
#2 | $31.3M | 116 | 7% | N/A | N/A |
#3 | $6.7M | 31 | 29% | N/A | N/A |
#4 | $25.4M | 84 | 8% | N/A | N/A |
#5 | $4.3M | 17 | -11% | N/A | N/A |
#6 | $25.9M | 96 | N/A | N/A | N/A |
#7 | $14.8M | 66 | 32% | N/A | N/A |
#8 | $17.6M | 75 | -29% | $47M | N/A |
#9 | $5.5M | 15 | -37% | N/A | N/A |
#10 | $6.5M | 29 | 16% | N/A | N/A |
What Is OncoLens?
OncoLens is a powerful tool for the conduct of clinical cancer conferences and care treatment planning. Our oncology focus allows us to assist our clients in optimizing patient care and making the accreditation process easier. The OncoLens platform: • Creates and manages tumor board schedules • Integrates into EMR for efficient collection of data • Allows for uploading of images from a PC or smartphone • HIPPA compliant • Provides CoC/NAPBC/NAPRC accreditation documentation • Automatically screens for clinical trial eligibility • Facilitates remote meetings • Notifies team members of outstanding items • Real-time collaboration Benefits of implementing OncoLens: • Up to a 90% decrease in tumor board time • Expedited case review • Increased number of cases reviewed • Higher quality care • Increased participation in clinical trials • Documentation needed for CoC or NAPBC accreditation Let us help you streamline the cancer conference process. Contact us at support@oncolens.com for a demo.
keywords:N/A
$23M
Total Funding
32
Number of Employees
$10.8M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Atlanta
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.7M | 32 | -3% | N/A |
#2 | $3.7M | 32 | -3% | N/A |
#3 | $9.1M | 32 | -11% | N/A |
#4 | $3.6M | 32 | 19% | N/A |
#5 | $3.5M | 32 | 7% | N/A |